{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:14:35Z","timestamp":1779236075995,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.101","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T09:15:48Z","timestamp":1510305348000},"page":"7322-7330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Chunling","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantao","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zishu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2017.10.101_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1875-9572(08)60024-8","article-title":"Enterovirus 71, one virus and many stories","volume":"49","author":"Wang","year":"2008","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.101_b0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/314032","article-title":"Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group","volume":"31","author":"Chan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.101_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"11","key":"10.1016\/j.vaccine.2017.10.101_b0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2017.10.101_b0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","article-title":"Diseases caused by enterovirus 71 infection","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Inf Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.101_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.101_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","article-title":"Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany","volume":"199","author":"Rabenau","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.10.101_b0040","first-page":"3341","article-title":"Severe hand-foot-and-mouth disease caused by mixed infec-tion of enterovirus 71 and coxsackie A16: reports of 6 cases","volume":"14","author":"Zhang","year":"2011","journal-title":"Chinese Gen Pract"},{"issue":"19","key":"10.1016\/j.vaccine.2017.10.101_b0045","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1128\/JVI.00561-06","article-title":"Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication","volume":"80","author":"Nayak","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.101_b0050","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.1320624111","article-title":"Neutralizing antibodies can initiate genome release from human enterovirus 71","volume":"111","author":"Plevka","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"10.1016\/j.vaccine.2017.10.101_b0055","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.101_b0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.101_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"26","key":"10.1016\/j.vaccine.2017.10.101_b0070","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2017.10.101_b0075","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.101_b0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1469-0691.2007.01904.x","article-title":"Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots","volume":"14","author":"Foo","year":"2008","journal-title":"Clin Microbiol Infect : Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.101_b0085","doi-asserted-by":"crossref","first-page":"e51957","DOI":"10.1371\/journal.pone.0051957","article-title":"A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses","volume":"7","author":"Wei","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.101_b0090","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4049\/jimmunol.1301439","article-title":"VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.101_b0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/wnan.119","article-title":"Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design","volume":"3","author":"Plummer","year":"2011","journal-title":"Wires Nanomed Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2017.10.101_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.05.001","article-title":"Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection","volume":"131","author":"Qiao","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.101_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(98)01599-3","article-title":"Hepatitis B core particles as a universal display model: a structure-function basis for development","volume":"442","author":"Pumpens","year":"1999","journal-title":"FEBS Lett"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2017.10.101_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0168-1656(95)00118-2","article-title":"Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes","volume":"44","author":"Schodel","year":"1996","journal-title":"J Biotechnol"},{"issue":"10","key":"10.1016\/j.vaccine.2017.10.101_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.micinf.2011.04.004","article-title":"A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice","volume":"13","author":"Wang","year":"2011","journal-title":"Microbes Infect"},{"issue":"15","key":"10.1016\/j.vaccine.2017.10.101_b0120","first-page":"18","article-title":"Tadaki Suzuki, Yasuko Tsunetsugu-Yokota, Yuko Sato. Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB-c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.pdf","volume":"88","author":"Naoko Iwata-Yoshikawa","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.101_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.03.065","article-title":"A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus","author":"Wu","year":"2017","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2017.10.101_b0130","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2017.10.101_b0135","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1016\/j.vaccine.2016.06.058","article-title":"Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges","volume":"34","author":"Yan","year":"2016","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2017.10.101_b0140","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.101_b0145","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.vaccine.2015.11.027","article-title":"Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.101_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11262-009-0440-4","article-title":"Detection of non-polio enteroviruses in Hungary 2000\u20132008 and molecular epidemiology of enterovirus 71, coxsackievirus A16, and echovirus 30","volume":"40","author":"Kapusinszky","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2017.10.101_b0155","doi-asserted-by":"crossref","first-page":"12973","DOI":"10.1038\/srep12973","article-title":"A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"issue":"39","key":"10.1016\/j.vaccine.2017.10.101_b0160","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2015.08.016","article-title":"Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71","volume":"33","author":"Zhang","year":"2015","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2017.10.101_b0165","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.10.101_b0170","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1080\/21645515.2015.1011975","article-title":"The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals","volume":"11","author":"Mao","year":"2015","journal-title":"Human Vaccines Immunother"},{"issue":"46","key":"10.1016\/j.vaccine.2017.10.101_b0175","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2010.08.080","article-title":"Combined peptides of human enterovirus 71 protect against virus infection in mice","volume":"28","author":"Liu","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.101_b0180","first-page":"e739","article-title":"Enterovirus 71 vaccine: close but still far","volume":"14","author":"Zhang","year":"2010","journal-title":"Int J Infect Dis : IJID : Off Publ Int Soc Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2017.10.101_b0185","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1016\/j.vaccine.2013.07.075","article-title":"Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design","volume":"31","author":"Joshi","year":"2013","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2017.10.101_b0190","doi-asserted-by":"crossref","first-page":"43281","DOI":"10.18632\/oncotarget.6533","article-title":"Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.101_b0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1542\/peds.2007-3735","article-title":"HLA-A33 is associated with susceptibility to enterovirus 71 infection","volume":"122","author":"Chang","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2017.10.101_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2010.03259.x","article-title":"The potential of CD4 T-cell memory","volume":"130","author":"McKinstry","year":"2010","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.vaccine.2017.10.101_b0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ni.2038","article-title":"Origins of CD4(+) effector and central memory T cells","volume":"12","author":"Pepper","year":"2011","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.101_b0210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.micinf.2007.11.009","article-title":"T cell epitope-based peptide-DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL\/6J mice","volume":"10","author":"Zhang","year":"2008","journal-title":"Microbes Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2017.10.101_b0215","doi-asserted-by":"crossref","first-page":"e25938","DOI":"10.1371\/journal.pone.0025938","article-title":"A human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virus","volume":"6","author":"Goodman","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.vaccine.2017.10.101_b0220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1203\/01.pdr.0000238247.86041.19","article-title":"Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71","volume":"60","author":"Chang","year":"2006","journal-title":"Pediatr Res"},{"issue":"26","key":"10.1016\/j.vaccine.2017.10.101_b0225","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2016.02.077","article-title":"Status of research and development of vaccines for enterovirus 71","volume":"34","author":"Reed","year":"2016","journal-title":"Vaccine"},{"issue":"52","key":"10.1016\/j.vaccine.2017.10.101_b0230","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.1016\/j.vaccine.2011.10.018","article-title":"Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines","volume":"29","author":"Liang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.101_b0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-11-79","article-title":"Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice","volume":"11","author":"Li","year":"2014","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2017.10.101_b0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eji.200425749","article-title":"High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins","volume":"35","author":"Liu","year":"2005","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.10.101_b0245","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s10529-009-0102-6","article-title":"Increasing M2 epitope density enhances systemic and mucosal immune responses to influenza A virus","volume":"31","author":"Pei","year":"2009","journal-title":"Biotechnol Lett"},{"issue":"9","key":"10.1016\/j.vaccine.2017.10.101_b0250","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2014.10.081","article-title":"Considerations for developing an immunization strategy with enterovirus 71 vaccine","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.10.101_b0255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000089375","article-title":"Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge","volume":"49","author":"Payette","year":"2006","journal-title":"Intervirol"},{"issue":"20","key":"10.1016\/j.vaccine.2017.10.101_b0260","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.vaccine.2017.03.065","article-title":"A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731530X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1731530X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T09:07:30Z","timestamp":1693213650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1731530X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":52,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X1731530X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}